Schizophrenia: Biological Mechanisms and Treatment Implications

Schizophrenia is a chronic neurodevelopmental disorder affecting ~1% of the population, characterized by positive (psychotic), negative, and cognitive symptoms. The biological perspective integrates genetics, neurobiology, and neurotransmission.

Genetic Architecture

• High heritability (~80%), but polygenic: thousands of common variants (GWAS: >280 loci) each with tiny effect (OR 1.01–1.1).
• Rare copy number variants (CNVs: 22q11.2 del, 16p11.2 dup) and damaging ultra-rare variants confer higher risk.
• Not deterministic—gene-environment interaction critical (e.g., cannabis, urbanicity, obstetric complications, childhood trauma).

Neurostructural Findings

• Reduced gray matter volume: Prefrontal cortex, hippocampus, superior temporal gyrus, thalamus — progressive in early illness.
• Ventricular enlargement.
• White matter disruption: Reduced fractional anisotropy (DTI) in corpus callosum, fronto-temporal tracts.
• Aberrant connectivity: Hypoconnectivity in default mode, frontoparietal networks; hyperconnectivity in salience/thalamic circuits.

Neurotransmitter Dysregulation

• Dopamine: Hyperdopaminergia in mesolimbic pathway → positive symptoms; hypodopaminergia in mesocortical pathway → negative/cognitive symptoms. Basis for antipsychotic D2 blockade.
• Glutamate: NMDA receptor hypofunction (ketamine/PCP model) → cortical disinhibition, gamma oscillation deficits, cognitive impairment. Target for novel agents (e.g., glycine site modulators).
• GABA: Parvalbumin interneuron deficit → impaired gamma synchrony.
• Others: Serotonin (5-HT2A), acetylcholine, neuregulin-1/ErbB4 signaling.

Treatment Translation

• Antipsychotics (D2/5-HT2A antagonists): Effective for positive symptoms; limited for negative/cognitive. Clozapine for treatment-resistant.
• Psychosocial: CBT-p, family psychoeducation, supported employment/education, cognitive remediation, ACT.
• Early intervention: Coordinated specialty care (CSC) for first-episode psychosis improves long-term trajectory.

Future Directions

Precision psychiatry: biomarkers for stratification, glutamatergic/modulatory agents, neuromodulation (TMS, DBS), digital phenotyping.

Schizophrenia is a disorder of distributed brain circuits—not a "broken" brain, but a differently wired one. Recovery is possible with comprehensive, sustained care.